ELI LILLY & Co — Director's Dealing 2013

Feb 11, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2013-02-08

Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-08	Common Stock	S	3000	$53.91	Disposed	26941	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2318	Indirect